CG
AUPH icon

Cutler Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cutler Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,600
Closed -$41K – 2287
2023
Q4 		$41K Buy
4,600
+3,743
+437% +$30.8K ﹤0.01% 1554
2023
Q3 		$6K Sell
857
-1,296
-60% -$12.7K ﹤0.01% 2735
2023
Q2 		$20K Sell
2,153
-794
-27% -$8.24K ﹤0.01% 1836
2023
Q1 		$32K Sell
2,947
-1,211
-29% -$10.7K ﹤0.01% 1625
2022
Q4 		$17K Buy
4,158
+900
+28% +$5.22K ﹤0.01% 2318
2022
Q3 		$24K Sell
3,258
-20,582
-86% -$178K ﹤0.01% 2462
2022
Q2 		$239K Sell
23,840
-3,573
-13% -$39.9K 0.02% 905
2022
Q1 		$339K Sell
27,413
-45,779
-63% -$708K 0.02% 862
2021
Q4 		$1.67M Buy
73,192
+25,559
+54% +$606K 0.07% 298
2021
Q3 		$1.05M Buy
47,633
+38,433
+418% +$610K 0.05% 440
2021
Q2 		$119K Buy
9,200
+8,500
+1,214% +$108K 0.01% 1718
2021
Q1 		$9K Sell
700
-4,600
-87% -$66.7K ﹤0.01% 3865
2020
Q4 		$73K Buy
5,300
+2,400
+83% +$34.9K ﹤0.01% 1732
2020
Q3 		$42K Buy
2,900
+400
+16% +$5.79K ﹤0.01% 1897
2020
Q2 		$40K Buy
+2,500
New +$40K ﹤0.01% 1892
2019
Q4 		– Sell
-2,800
Closed -$25.8K – 3963
2019
Q3 		$14K Sell
2,800
-2,700
-49% -$16.3K ﹤0.01% 2393
2019
Q2 		$36K Buy
5,500
+1,400
+34% +$8.92K ﹤0.01% 1785
2019
Q1 		$26K Sell
4,100
-500
-11% -$3.32K ﹤0.01% 1846
2018
Q4 		$31K Buy
+4,600
New +$26.5K ﹤0.01% 1786
2018
Q2 		– Sell
-600
Closed -$3.35K – 4166
2018
Q1 		$3K Sell
600
-1,900
-76% -$10.2K ﹤0.01% 3516
2017
Q4 		$11K Sell
2,500
-2,800
-53% -$15.5K ﹤0.01% 3024
2017
Q3 		$33K Sell
5,300
-48,141
-90% -$303K ﹤0.01% 2635
2017
Q2 		$327K Buy
53,441
+26,001
+95% +$175K 0.01% 944
2017
Q1 		$201K Buy
27,440
+26,440
+2,644% +$122K 0.01% 1187
2016
Q4 		$2K Buy
+1,000
New +$3.22K ﹤0.01% 5543

Other funds holding AUPH

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cutler Group's AUPH Position: Q1 2024 in Review

Cutler Group sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2024, closing a stake of 4,600 shares — an estimated $41K sold.

Cutler Group first reported a position in AUPH in Q4 2016 and held it in 25 quarters. The position peaked at $1.67M in Q4 2021. 179 funds tracked by Wall St. Rank hold AUPH as of Q1 2024.

  • Cutler Group reported no remaining Aurinia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 4,600 Aurinia Pharmaceuticals shares in Q1 2024, an estimated $41K.
  • Cutler Group first reported a position in Aurinia Pharmaceuticals in Q4 2016 and held it in 25 quarters.
  • Cutler Group's Aurinia Pharmaceuticals position peaked at $1.67M in Q4 2021.
  • 179 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.